查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1442495

α 澱粉酶的全球市場 - 全球產業分析、規模、佔有率、成長、趨勢、預測 (2031) - 按形式、按應用、按原料、按地區

Alpha Amylase Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 300 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球 α 澱粉酶市場規模預計將從 2023 年的 18 億美元快速成長到 2031 年底的 25 億美元。

消費者健康意識的提高正在導致食品消費模式發生重大變化。 隨著消費者的健康意識越來越強，他們越來越喜歡有益於健康和營養的產品。 α澱粉酶以其消化健康益處和免疫系統支持而聞名，並且需求隨著這一趨勢而不斷增加。 消費者對健康食品選擇的認識不斷增強，市場可望受益。

在製藥業，對 α 澱粉酶的需求不斷增長，因為它具有多種健康益處，包括免疫系統支持、發炎管理和血糖水平正常化。 科學證明，α 澱粉酶可幫助消化並提供能量，在醫學上具有廣泛的應用，可對抗消化系統疾病並支持整體健康。 由於久坐的生活方式和不健康的飲食導致胃腸道疾病的增加，製藥業為 α 澱粉酶市場的擴張提供了一個充滿希望的途徑。

歐洲在全球 α 澱粉酶市場展現壓倒性的實力，2023 年銷售佔有率最高，達 28.0%。 該地區先進的生物技術產業和廣泛的最終用戶群有助於其市場領先地位，並為持續成長和創新奠定了基礎。

在南亞，α 澱粉酶市場預計到 2031 年底將顯著成長。 該地區的複合年增長率預計為 9.4%，消費者偏好的變化以及食品和製藥行業的擴張將推動該地區的發展，為市場參與者提供利潤豐厚的機會。

本報告調查了全球 α 澱粉酶市場，並提供了市場概況、按形式、應用、原材料、地區劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第三章2018-2023年生產與貿易統計

第 4 章價格分析，2018-2023

第 5 章 2018-2031 年全球 α 澱粉酶市場前景

  • 2018-2031 年全球 α 澱粉酶市場前景，以形式、價值（十億美元）、數量（單位）劃分
  • 2018-2031 年全球 α 澱粉酶市場前景（按應用劃分）、價值（十億美元）、數量（單位）
  • 2018-2031 年全球 α 澱粉酶市場前景（按原料、價值（十億美元）、數量（單位））
  • 2018-2031 年全球 α 澱粉酶市場前景（按地區、價值（十億美元）、數量（單位））

第 6 章北美 α 澱粉酶市場展望，2018-2031

第 7 章歐洲 α-澱粉酶市場展望，2018-2031

第 8 章亞太地區 α 澱粉酶市場展望，2018-2031

第 9 章拉丁美洲 α 澱粉酶市場前景，2018-2031

第 10 章中東與非洲 α 澱粉酶市場前景，2018-2031 年

第十一章競爭態勢

  • 以最終使用者和使用情況劃分的熱圖
  • 2022 年公司市佔率分析
  • 競爭對手儀表板
  • 公司簡介
    • Novozymes
    • Aumgene Biosciences
    • Lee BioSolutions
    • AB Enzymes
    • Infinita Biotech Private Limited
    • Jiangsu Boli Bioproducts Co., Ltd.
    • Actiza Pharmaceutical Private Limited
    • Brisk Bioscience.
    • Sisco Research Laboratories Pvt Ltd
    • Karyotica Biologicals
    • Biolaxi Corporation
    • Creative Enzymes
    • Rejoice Life Ingredients
    • Enzyme Bioscience Pvt. Ltd.
    • Sunson Industry Group Co., Ltd.

第12章附錄

簡介目錄

The global alpha amylase market is set to witness robust growth in the coming years, according to a comprehensive market analysis covering the period from 2024 to 2031. The market is anticipated to surge from US$ 1.8 billion in 2023 to a staggering US$ 2.5 billion by the end of 2031. The analysis, which delves into various aspects of the market landscape, sheds light on key trends, regional insights, category-wise outlook, and competitive dynamics shaping the alpha amylase industry.

Rising Consumer Awareness Regarding Health Beneficial Products

Increasing consumer awareness regarding health and wellness is driving significant shifts in food consumption patterns. As consumers become more health-conscious, there is a growing preference for products offering enhanced health and nutrition benefits. Alpha amylase, known for its digestive health benefits and immune system support, is witnessing increased demand in line with this trend. The market is poised to benefit from this heightened consumer consciousness towards healthier food choices.

Bio-preservation Trend Fuelling Alpha Amylase Demand in Food Industry

Bio-preservation, aimed at extending the shelf life of food products through natural means, is gaining traction among consumers seeking safer and fresher food options. With artificial preservatives falling out of favor, alpha amylase emerges as a crucial component in the bio-preservation process. Its ability to maintain food freshness while meeting safety standards aligns with consumer preferences for clean label, natural products, thus driving its demand across various food sectors including dairy, beverages, and bakery.

Increasing Demand of Alpha Amylase in Pharmaceutical Industry to Bolster Sales

The pharmaceutical industry is witnessing a growing demand for alpha amylase, attributed to its various health benefits including immune system support, inflammation management, and blood sugar normalization. Scientifically proven to aid digestion and provide energy, alpha amylase is finding extensive applications in medicines aimed at addressing digestive disorders and supporting overall health. With sedentary lifestyles and unhealthy dietary habits contributing to the rise in digestive issues, the pharmaceutical sector presents a promising avenue for alpha amylase market expansion.

High Cost of Alpha Amylase to Hamper Sales

Despite its promising prospects, the high cost associated with alpha amylase remains a significant challenge for market growth. The intricate production process and sensitivity to environmental factors contribute to its expensive nature, deterring potential customers. While advancements in production methods have opened new possibilities, the premium pricing of alpha amylase continues to pose hurdles in widespread adoption.

Country-wise Insights

Europe Dominates Global Alpha Amylase Market

Europe emerges as the dominant force in the global alpha amylase market, boasting the highest volume share of 28.0% in 2023. The region's advanced biotechnology industry and extensive end-user base contribute to its market leadership, setting the stage for continued growth and innovation.

South Asia Presents Promising Growth Opportunities

In South Asia, the alpha amylase market is forecasted to exhibit substantial growth by the end of 2031. With a projected CAGR of 9.4%, the region presents lucrative opportunities for market players, fueled by evolving consumer preferences and expanding food and pharmaceutical sectors.

Category-wise Insights

Bakery Segment to Witness Steady Growth

Within the food and beverage industry, the bakery segment stands out with a projected CAGR of 8.3%. Alpha amylase's ability to enhance shelf life and improve baking volume positions it as a valuable ingredient in bakery products, driving market growth. Additionally, the demand for alpha amylase in confectionary and bio-preservation applications is on the rise, further bolstering market prospects.

Powder Form Dominates Market Share

Among different forms of alpha amylase, powder holds the largest market share, accounting for 79.3% of the global market. Its easy availability and versatility make it a preferred choice for various applications, although liquid alpha amylase is also witnessing increasing demand owing to its diverse application possibilities.

Competitive Analysis

Leading players in the global alpha amylase market, including Novozymes, Lee BioSolution, and AB Enzymes, are focusing on product diversification and research and development initiatives to maintain their competitive edge. Strategic partnerships, acquisitions, and custom manufacturing services are key strategies employed by these players to expand their market presence and cater to evolving customer needs.

The market also sees active participation from companies such as Aumgene Biosciences, Jiangsu Boli Bioproducts Co., Ltd., Ottokemi, Lee Biosolutions, Inc., and Karyotica Biologicals Pvt. Ltd., each leveraging unique capabilities and strategies to capitalize on emerging opportunities and drive innovation within the industry.

Alpha Amylase Industry Research by Category

By Form:

  • Powder & Granules
  • Liquid

By Application:

  • Food & Beverage Industry
    • Confectionery
    • Bakery
    • Brewing
    • Other Processed Food
  • Pharmaceuticals
  • Animal Feed
  • Research
  • Detergent
  • Others

By Source:

  • Bacteria
  • Fungi
  • Plants & Animals

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Alpha Amylase Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Ankle Syndesmosis Treatment Devices Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Form, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Ankle Syndesmosis Treatment Devices Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Alpha Amylase Market Outlook, 2018 - 2031

  • 5.1. Global Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Powder & Granules
      • 5.1.1.2. Liquid
  • 5.2. Global Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Food & Beverage Industry
        • 5.2.1.1.1. Confectionery
        • 5.2.1.1.2. Bakery
        • 5.2.1.1.3. Brewing
        • 5.2.1.1.4. Other Processed Food
      • 5.2.1.2. Pharmaceuticals
      • 5.2.1.3. Animal Feed
      • 5.2.1.4. Research
      • 5.2.1.5. Detergent
      • 5.2.1.6. Others
  • 5.3. Global Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Bacteria
      • 5.3.1.2. Fungi
      • 5.3.1.3. Plants & Animals
  • 5.4. Global Alpha Amylase Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Alpha Amylase Market Outlook, 2018 - 2031

  • 6.1. North America Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Powder & Granules
      • 6.1.1.2. Liquid
  • 6.2. North America Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Food & Beverage Industry
        • 6.2.1.1.1. Confectionery
        • 6.2.1.1.2. Bakery
        • 6.2.1.1.3. Brewing
        • 6.2.1.1.4. Other Processed Food
      • 6.2.1.2. Pharmaceuticals
      • 6.2.1.3. Animal Feed
      • 6.2.1.4. Research
      • 6.2.1.5. Detergent
      • 6.2.1.6. Others
  • 6.3. North America Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Bacteria
      • 6.3.1.2. Fungi
      • 6.3.1.3. Plants & Animals
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.2. U.S. Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.3. U.S. Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.4. Canada Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.5. Canada Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.6. Canada Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Alpha Amylase Market Outlook, 2018 - 2031

  • 7.1. Europe Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Powder & Granules
      • 7.1.1.2. Liquid
  • 7.2. Europe Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Food & Beverage Industry
        • 7.2.1.1.1. Confectionery
        • 7.2.1.1.2. Bakery
        • 7.2.1.1.3. Brewing
        • 7.2.1.1.4. Other Processed Food
      • 7.2.1.2. Pharmaceuticals
      • 7.2.1.3. Animal Feed
      • 7.2.1.4. Research
      • 7.2.1.5. Detergent
      • 7.2.1.6. Others
  • 7.3. Europe Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Bacteria
      • 7.3.1.2. Fungi
      • 7.3.1.3. Plants & Animals
    • 7.3.2. Attractiveness Analysis
  • 7.4. Europe Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.2. Germany Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.3. Germany Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.4. U.K. Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.5. U.K. Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.6. U.K. Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.7. France Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.8. France Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.9. France Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.10. Italy Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.11. Italy Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.12. Italy Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.13. Turkey Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.14. Turkey Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.15. Turkey Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.16. Russia Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.17. Russia Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.18. Russia Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Alpha Amylase Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Powder & Granules
      • 8.1.1.2. Liquid
  • 8.2. Asia Pacific Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Food & Beverage Industry
        • 8.2.1.1.1. Confectionery
        • 8.2.1.1.2. Bakery
        • 8.2.1.1.3. Brewing
        • 8.2.1.1.4. Other Processed Food
      • 8.2.1.2. Pharmaceuticals
      • 8.2.1.3. Animal Feed
      • 8.2.1.4. Research
      • 8.2.1.5. Detergent
      • 8.2.1.6. Others
  • 8.3. Asia Pacific Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Bacteria
      • 8.3.1.2. Fungi
      • 8.3.1.3. Plants & Animals
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.2. China Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.3. China Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.4. Japan Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.5. Japan Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.6. Japan Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.7. South Korea Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.8. South Korea Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.9. South Korea Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.10. India Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.11. India Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.12. India Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Alpha Amylase Market Outlook, 2018 - 2031

  • 9.1. Latin America Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Powder & Granules
      • 9.1.1.2. Liquid
  • 9.2. Latin America Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.2.1.1. Food & Beverage Industry
        • 9.2.1.1.1. Confectionery
        • 9.2.1.1.2. Bakery
        • 9.2.1.1.3. Brewing
        • 9.2.1.1.4. Other Processed Food
      • 9.2.1.2. Pharmaceuticals
      • 9.2.1.3. Animal Feed
      • 9.2.1.4. Research
      • 9.2.1.5. Detergent
      • 9.2.1.6. Others
  • 9.3. Latin America Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Bacteria
      • 9.3.1.2. Fungi
      • 9.3.1.3. Plants & Animals
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.2. Brazil Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.3. Brazil Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.4. Mexico Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.5. Mexico Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.6. Mexico Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.7. Argentina Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.8. Argentina Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.9. Argentina Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Alpha Amylase Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Powder & Granules
      • 10.1.1.2. Liquid
  • 10.2. Middle East & Africa Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Food & Beverage Industry
        • 10.2.1.1.1. Confectionery
        • 10.2.1.1.2. Bakery
        • 10.2.1.1.3. Brewing
        • 10.2.1.1.4. Other Processed Food
      • 10.2.1.2. Pharmaceuticals
      • 10.2.1.3. Animal Feed
      • 10.2.1.4. Research
      • 10.2.1.5. Detergent
      • 10.2.1.6. Others
  • 10.3. Middle East & Africa Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Bacteria
      • 10.3.1.2. Fungi
      • 10.3.1.3. Plants & Animals
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.2. GCC Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.3. GCC Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.4. South Africa Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.5. South Africa Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.6. South Africa Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.7. Egypt Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.8. Egypt Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.9. Egypt Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.10. Nigeria Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.11. Nigeria Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.12. Nigeria Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Application Heatmap
  • 11.2. Company Market Share Analysis, 2022
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Novozymes
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Aumgene Biosciences
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Lee BioSolutions
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. AB Enzymes
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Infinita Biotech Private Limited
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Jiangsu Boli Bioproducts Co., Ltd.
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Actiza Pharmaceutical Private Limited
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Brisk Bioscience.
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Sisco Research Laboratories Pvt Ltd
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development
    • 11.4.10. Karyotica Biologicals
      • 11.4.10.1. Company Overview
      • 11.4.10.2. Product Portfolio
      • 11.4.10.3. Financial Overview
      • 11.4.10.4. Business Strategies and Development
    • 11.4.11. Biolaxi Corporation
      • 11.4.11.1. Company Overview
      • 11.4.11.2. Product Portfolio
      • 11.4.11.3. Financial Overview
      • 11.4.11.4. Business Strategies and Development
    • 11.4.12. Creative Enzymes
      • 11.4.12.1. Company Overview
      • 11.4.12.2. Product Portfolio
      • 11.4.12.3. Financial Overview
      • 11.4.12.4. Business Strategies and Development
    • 11.4.13. Rejoice Life Ingredients
      • 11.4.13.1. Company Overview
      • 11.4.13.2. Product Portfolio
      • 11.4.13.3. Financial Overview
      • 11.4.13.4. Business Strategies and Development
    • 11.4.14. Enzyme Bioscience Pvt. Ltd.
      • 11.4.14.1. Company Overview
      • 11.4.14.2. Product Portfolio
      • 11.4.14.3. Financial Overview
      • 11.4.14.4. Business Strategies and Development
    • 11.4.15. Sunson Industry Group Co., Ltd.
      • 11.4.15.1. Company Overview
      • 11.4.15.2. Product Portfolio
      • 11.4.15.3. Financial Overview
      • 11.4.15.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations